A central role for RNA in the induction and biological activities of type 1 interferons
- PMID: 21956969
- DOI: 10.1002/wrna.32
A central role for RNA in the induction and biological activities of type 1 interferons
Abstract
In mammals the type 1 interferon (IFN) system functions as the primary innate antiviral defense and more broadly as a stress response and regulator of diverse homeostatic mechanisms. RNA plays a central role in the induction of IFN and in its biologic activities. Cellular toll-like receptors (TLR), RIG-I-like receptors (RLR), and nucleotide organization domain-like receptors (NLR) sense pathogen- and danger-associated RNAs as nonself based on structural features and subcellular location that distinguish them from ubiquitous host RNAs. Detection of nonself RNAs activates signaling pathways to induce IFN transcription and secretion. In turn, IFN binds cell surface receptors to initiate signaling that results in the induction of IFN-stimulated genes (ISGs) that mediate its biologic activities. RNA also plays a critical role in this effector phase of the IFN system, serving as an activator of enzyme activity for protein kinase RNA-dependent (PKR) and oligoadenylate synthetase (OAS), and as a substrate for 2('), 5(') -linked oligoadenylate dependant-endoribonuclease (RNase-L). In contrast to the transcriptional response induced by RNA receptors, these key ISGs mediate their activities primarily through post transcriptional mechanisms to regulate the translation and stability of host and microbial RNAs. Together RNA-sensing and RNA-effector molecules comprise a network of coordinately regulated proteins with integrated feedback and feed-forward loops that tightly regulate the cellular response to RNA. This stringent regulation is essential to prevent deleterious effects of uncontrolled IFN expression and effector activation. In light of this extensive crosstalk, targeting key mediators of the cellular response to RNA represents a viable strategy for therapeutic modulation of immune function and treatment of diseases in which this response is dysregulated (e.g., cancer).
Copyright © 2010 John Wiley & Sons, Ltd.
Similar articles
-
Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.Immunol Rev. 2009 Jan;227(1):44-53. doi: 10.1111/j.1600-065X.2008.00723.x. Immunol Rev. 2009. PMID: 19120474 Review.
-
Nucleic acid-induced antiviral immunity in shrimp.Antiviral Res. 2013 Sep;99(3):270-80. doi: 10.1016/j.antiviral.2013.05.016. Epub 2013 Jun 15. Antiviral Res. 2013. PMID: 23773856
-
IRF-7 is the master regulator of type-I interferon-dependent immune responses.Nature. 2005 Apr 7;434(7034):772-7. doi: 10.1038/nature03464. Epub 2005 Mar 30. Nature. 2005. PMID: 15800576
-
The antiviral innate immune response in fish: evolution and conservation of the IFN system.J Mol Biol. 2013 Dec 13;425(24):4904-20. doi: 10.1016/j.jmb.2013.09.033. Epub 2013 Sep 27. J Mol Biol. 2013. PMID: 24075867 Review.
-
Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.J Immunol. 2010 Jun 1;184(11):6447-56. doi: 10.4049/jimmunol.0901750. Epub 2010 Apr 30. J Immunol. 2010. PMID: 20435932
Cited by
-
TDP-1, the Caenorhabditis elegans ortholog of TDP-43, limits the accumulation of double-stranded RNA.EMBO J. 2014 Dec 17;33(24):2947-66. doi: 10.15252/embj.201488740. Epub 2014 Nov 12. EMBO J. 2014. PMID: 25391662 Free PMC article.
-
The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors.J Biol Chem. 2015 Aug 7;290(32):19681-96. doi: 10.1074/jbc.M115.653113. Epub 2015 Jun 8. J Biol Chem. 2015. PMID: 26055709 Free PMC article.
-
Noncoding subgenomic flavivirus RNA: multiple functions in West Nile virus pathogenesis and modulation of host responses.Viruses. 2014 Jan 27;6(2):404-27. doi: 10.3390/v6020404. Viruses. 2014. PMID: 24473339 Free PMC article. Review.
-
Integrative RNA-seq and microarray data analysis reveals GC content and gene length biases in the psoriasis transcriptome.Physiol Genomics. 2014 Aug 1;46(15):533-46. doi: 10.1152/physiolgenomics.00022.2014. Epub 2014 May 20. Physiol Genomics. 2014. PMID: 24844236 Free PMC article.
-
Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.Infect Immun. 2014 Jul;82(7):2802-14. doi: 10.1128/IAI.00105-14. Epub 2014 Apr 14. Infect Immun. 2014. PMID: 24733098 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources